MOVE Share Price Performance
CHF 151.80
45.40 (42.67%)
8.9% undervalued intrinsic discount
CHF 166.69
Fair Value
Price CHF 151.80
AnalystConsensusTarget CHF 166.69
Fair ValueCHF 166.69
Share Pricen/a
Medacta Group SA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
MOVE Community Narratives
AN
Fair Value CHF 166.69 8.9% undervalued intrinsic discount
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
Key Takeaways Geographic and strategic acquisitions promise revenue growth through enhanced market penetration and operational capabilities, especially in sports medicine. Innovative product rollouts and medical education investments are expected to drive revenue by capturing market share and increasing solution adoption.Read more
25
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
CHF 166.69
8.9% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
12.37% p.a.
Profit Margin
13.56%
Future PE
32.92x
Price in 2028
CHF 191.09
Trending Discussion
Recently Updated Narratives
AN
MOVE: Lower Risk And Steady Margins Will Support Gradual Performance Outlook
Fair Value: CHF 166.69 8.9% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medacta Group SA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Mar 13, 2026
- 4.76
- 67.61%
- 14.69%
- 48.0%
About MOVE
- Founded
- 1958
- Employees
- 2041
- CEO
- WebsiteView website
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
